Silence Therapeutics PLC | Mutual Funds
Mutual Funds that own Silence Therapeutics PLC
Invesco Perpetual UK 2 Invt. Series - UK Strategic Income Fund
4,166,667
5.95%
0
1.26%
03/29/2018
CF Woodford Equity Income
3,424,047
4.88%
0
0.08%
07/31/2018
Perpetual Income & Growth Investment Trust Plc
3,333,333
4.76%
0
0.43%
03/31/2018
Henderson Invt. Fds. Series I - UK & Irish Smaller Companies
1,265,726
1.81%
0
1.01%
07/31/2018
Polar Capital European Forager Fund Ltd.
961,664
1.37%
-38,336
0.22%
12/31/2016
Keystone Investment Trust Plc
781,131
1.12%
0
0.31%
04/30/2018
Aviva Investors Investment Funds ICVC - European Equity Fund
156,300
0.22%
-14,354
0.11%
10/15/2017
Aviva Investors - European Equity Fund
119,537
0.17%
0
0.11%
06/30/2018
PPF (PMG Partners Funds) - CP Global BioPharma Fund
4,370
0.01%
0
0.02%
05/31/2018
| Address |
72 Hammersmith Road
London Greater London W14 8TH
United Kingdom
|
|
Employees
|
- |
| Website |
http://silence-therapeutics.com |
| Updated |
07/08/2019 |
| Silence Therapeutics Plc engages in the development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. |
